Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Brief Bioinform ; 23(5)2022 09 20.
Artículo en Inglés | MEDLINE | ID: mdl-35514205

RESUMEN

BACKGROUND: Coronavirus disease 2019 (COVID-19) has spurred a boom in uncovering repurposable existing drugs. Drug repurposing is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. MOTIVATION: Current works of drug repurposing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are mostly limited to only focusing on chemical medicines, analysis of single drug targeting single SARS-CoV-2 protein, one-size-fits-all strategy using the same treatment (same drug) for different infected stages of SARS-CoV-2. To dilute these issues, we initially set the research focusing on herbal medicines. We then proposed a heterogeneous graph embedding method to signaled candidate repurposing herbs for each SARS-CoV-2 protein, and employed the variational graph convolutional network approach to recommend the precision herb combinations as the potential candidate treatments against the specific infected stage. METHOD: We initially employed the virtual screening method to construct the 'Herb-Compound' and 'Compound-Protein' docking graph based on 480 herbal medicines, 12,735 associated chemical compounds and 24 SARS-CoV-2 proteins. Sequentially, the 'Herb-Compound-Protein' heterogeneous network was constructed by means of the metapath-based embedding approach. We then proposed the heterogeneous-information-network-based graph embedding method to generate the candidate ranking lists of herbs that target structural, nonstructural and accessory SARS-CoV-2 proteins, individually. To obtain precision synthetic effective treatments forvarious COVID-19 infected stages, we employed the variational graph convolutional network method to generate candidate herb combinations as the recommended therapeutic therapies. RESULTS: There were 24 ranking lists, each containing top-10 herbs, targeting 24 SARS-CoV-2 proteins correspondingly, and 20 herb combinations were generated as the candidate-specific treatment to target the four infected stages. The code and supplementary materials are freely available at https://github.com/fanyang-AI/TCM-COVID19.


Asunto(s)
Tratamiento Farmacológico de COVID-19 , Combinación de Medicamentos , Reposicionamiento de Medicamentos/métodos , Drogas en Investigación , Humanos , SARS-CoV-2
2.
Methods ; 145: 51-59, 2018 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-29879508

RESUMEN

Drug-disease associations provide important information for drug discovery and drug repositioning. Drug-disease associations can induce different effects, and the therapeutic effect attracts wide spread interest. Therefore, developing drug-disease association prediction methods is an important task, and differentiating therapeutic associations from other associations is also very important. In this paper, we formulate the known drug-disease associations as a bipartite network, and then present a novel representation for drugs and diseases based on the bipartite network and linear neighborhood similarity. Thus, we propose the network topological similarity-based inference method (NTSIM) to predict unobserved drug-disease associations. Further, we extend the work to the association classification, and propose the network topological similarity-based classification method (NTSIM-C) to differentiate therapeutic associations from others. Compared with existing drug-disease association prediction methods, NTSIM can produce superior performances in predicting drug-disease associations, and NTSIM-C can accurately classify drug-disease associations. Further, we analyze the capability of proposed methods by using several case studies. The studies show the usefulness of NTSIM and NTSIM-C in the real applications. In conclusion, NTSIM and NTSIM-C are promising for predicting drug-disease associations and their therapeutic functions.


Asunto(s)
Algoritmos , Biología Computacional/métodos , Descubrimiento de Drogas/métodos , Reposicionamiento de Medicamentos/métodos , Humanos
3.
BMC Med Inform Decis Mak ; 19(Suppl 6): 264, 2019 12 19.
Artículo en Inglés | MEDLINE | ID: mdl-31856802

RESUMEN

BACKGROUND: Traditional Chinese medicine (TCM) is a highly important complement to modern medicine and is widely practiced in China and in many other countries. The work of Chinese medicine is subject to the two factors of the inheritance and development of clinical experience of famous Chinese medicine practitioners and the difficulty in improving the service capacity of basic Chinese medicine practitioners. Heterogeneous information networks (HINs) are a kind of graphical model for integrating and modeling real-world information. Through HINs, we can integrate and model the large-scale heterogeneous TCM data into structured graph data and use this as a basis for analysis. METHODS: Mining categorizations from TCM data is an important task for precision medicine. In this paper, we propose a novel structured learning model to solve the problem of formula regularity, a pivotal task in prescription optimization. We integrate clustering with ranking in a heterogeneous information network. RESULTS: The results from experiments on the Pharmacopoeia of the People's Republic of China (ChP) demonstrate the effectiveness and accuracy of the proposed model for discovering useful categorizations of formulas. CONCLUSIONS: We use heterogeneous information networks to model TCM data and propose a TCM-HIN. Combining the heterogeneous graph with the probability graph, we proposed the TCM-Clus algorithm, which combines clustering with ranking and classifies traditional Chinese medicine prescriptions. The results of the categorizations can help Chinese medicine practitioners to make clinical decision.


Asunto(s)
Análisis por Conglomerados , Servicios de Información/normas , Medicina Tradicional China/estadística & datos numéricos , Medicina de Precisión/estadística & datos numéricos , China , Minería de Datos , Humanos , Farmacopeas como Asunto , Prescripciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA